Out-of-pocket costs are the strongest predictor of abandonment: High OOP costs drive non-adherence, especially in obesity, where coverage is limited and stigma persists
Abstract Breast cancer, characterized by unique epidemiological patterns and significant heterogeneity, remains one of the leading causes of malignancy-related deaths in women
This understanding offers reassurance to many individuals who are dedicated to their health and weight loss goals
At the tirzepatide 15mg/weekly dose, the most commonly reported side effects included: Nausea: 24.08% Diarrhea: 20.79% Belching: 16.42% Bloating: 16.29% Gut discomfort: 14.86% Vomiting: 13.98% Constipation: 8.86% Indigestion: 8.52% Abdominal pain: 7.57% Hypersensitivity reactions affected 2-4% of participants
Oral NAD+ (NR/NMN): Most convenient and affordable, but slower to take effect and has lower bioavailability
If a dose of epithalon is missed it should be taken as soon as possible